Has Frank Liporace, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,678,062 in general payments to Frank Liporace, MD across 907 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Frank Liporace, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Frank Liporace, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Frank Liporace, MD

Orthopaedic Trauma · Jersey City, NJNPI 1689679722

Payments from drug & device makers

$3,678,062in general payments, 2019–2025

Across 907 payments — averaging $4055.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Depuy Synthes Products, Inc.$2M
Zimmer Biomet$1.3M
Stryker$77K
Medical Device Business Services, Inc.$68K
Royal Biologics, Inc.$61K
Smith+Nephew$49K
plus $79K from 54 others

What the payments were for

Royalty or licence$3,180,05588%
Consulting fees$339,1009%
Speaking & faculty fees$7,5840%
Travel & lodging$40,6751%
Food & beverage$37,1031%
Education$8,5350%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Depuy Synthes Products, Inc.	19	$2,039,167
Zimmer Biomet	298	$1,305,663
Stryker(2 entities)	85	$76,593
Medical Device Business Services, Inc.	71	$67,502
Royal Biologics, Inc.	60	$61,028
Smith+Nephew	64	$48,904
Conventus Orthopaedics, Inc.	3	$18,000
Synthes USA Products LLC	7	$14,704
Biocomposites Inc	8	$14,269
US Implant Solutions, LLC	9	$9,081
Johnson & Johnson(2 entities)	85	$5,556
Acera Surgical, Inc.	24	$3,162
Flower Orthopedics Coporation	2	$2,506
Synthes GmbH	3	$1,940
Globus Medical(2 entities)	17	$1,821
Kerecis Limited	10	$1,420
Baxter Healthcare	3	$715
Nuvasive Specialized Orthopedics, Inc.	3	$490
Sanara Medtech Inc.	4	$475
Si-bone, Inc.	11	$465
Organogenesis Inc.	5	$429
Heron Therapeutics, Inc.	15	$300
Pacira Pharmaceuticals Incorporated	3	$273
Heraeus Medical, LLC.	6	$238
Acumed LLC	3	$189
Medtronic(2 entities)	5	$187
Next Science LLC	5	$177
Axogen	8	$168
Stability Biologics, LLC	2	$156
Curvafix, Inc.	1	$150
Trimed, Inc.	1	$146
Carbofix Orthopedics Inc	2	$139
Pfizer	9	$135
Davol Inc.	3	$133
Fusion Orthopedics USA, LLC	1	$128
Kinamed, Inc.	1	$123
Integra Lifesciences Corporation	1	$122
KCI USA, Inc.	3	$121
Conformis, Inc.	2	$117
Medshape, Inc.	3	$116
Onkos Surgical, Inc.	1	$115
Sanofi-aventis U.S. LLC	7	$111
Avanos Medical	3	$88
Bioventus LLC	4	$82
AMDT Holdings, Inc.	1	$79
Pacira Therapeutics, Inc.	4	$76
Seapearl East, Inc	1	$72
Dynasplint Systems Inc.	1	$66
AbbVie	4	$55
Vertex	3	$47
Paragon 28, Inc.	3	$42
Bonalive Inc	1	$35
ERMI LLC	1	$27
Conmed Corporation	1	$26
Baudax Bio Inc.	1	$25
Supernus Pharmaceuticals, Inc.	1	$22
Ferring Pharmaceuticals Inc.	1	$21
Fidia Pharma USA Inc.	1	$18
Synergy Orthopedics, LLC	1	$17
AstraZeneca	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic trauma providers in New Jerseyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$323,100

Medicare patients

249

Services billed

1,619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	160	$5,079
Lidocaine	12	$1,001
Gabapentin	30	$204
Famotidine	16	$117
Celecoxib	16	$101
Oxycodone Hcl	22	$69
Meloxicam	17	$55

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Jersey City

Mark ReillyNewark$540K
Milan SenClifton$172K
Mark AdamsNewark$38K
Julie KellerMaywood$29K
Joseph GallowayNewark$15K
Richard SchenkWhippany$10K
Sergio PulidoMoorestown$10K
David HamptonMedford$9K
Steven MennonaManasquan$8K
Jason SchneidkrautWayne$4K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →